Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis

Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 131; no. 2; pp. 379 - 386
Main Authors Meltzer, Eli O., MD, Schatz, Michael, MD, Nathan, Robert, MD, Garris, Cindy, MS, Stanford, Richard H., PharmD, MS, Kosinski, Mark, MS
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.02.2013
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly ( P  < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusion The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
AbstractList Background: The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective: We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods: A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results: Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (PANB<ANB.001) across patient groups, differing in TNSS (FANB=ANB72.7), Physician's Global Assessment score (FANB=ANB28.6), and disease severity (FANB=ANB34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusions: The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
BACKGROUNDThe Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control.OBJECTIVEWe sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID).METHODSA total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients.RESULTSInternal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant.CONCLUSIONThe RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly ( P  < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusion The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID). Methods A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients. Results Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant. Conclusion The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
Author Schatz, Michael, MD
Garris, Cindy, MS
Meltzer, Eli O., MD
Stanford, Richard H., PharmD, MS
Kosinski, Mark, MS
Nathan, Robert, MD
Author_xml – sequence: 1
  fullname: Meltzer, Eli O., MD
– sequence: 2
  fullname: Schatz, Michael, MD
– sequence: 3
  fullname: Nathan, Robert, MD
– sequence: 4
  fullname: Garris, Cindy, MS
– sequence: 5
  fullname: Stanford, Richard H., PharmD, MS
– sequence: 6
  fullname: Kosinski, Mark, MS
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27105701$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23219170$$D View this record in MEDLINE/PubMed
BookMark eNqFUl2LEzEUDbLidqt_wAcJiOCDU28yH8nAIizFL1gQ1vU5ZDJ3aLrTTM2dVvrvzWyrC_ugT0luzjk5N-desLMwBGTspYCFAFG9Xy_W1vmFBCFTYQFSPmEzAbXKKi3LMzYDqEVWqaI-ZxdEa0jnXNfP2LnMpaiFghm7u8He28b3fjy843vb-_Z-Z0PLI9J2COT3GJCIDx0fV8hvVj740RNfDmGMQ8-viNL1BsPIb5FG7gPf2tGnM_FfflzxeGI8Z0872xO-OK1z9uPTx9vll-z62-evy6vrzJUgx8w5LWoo8lIXpaiKRteiAy2d7rCoWgVKdVq3ZedK1zZSFw3YopUqB4td0zmZz9nbo-42Dj93yZLZeHLY9zbgsCMjcplrkYPW_4cmfamrAkSCvn4EXQ-7GFIjJrksVAlVMj1n8ohycSCK2Jlt9BsbD0aAmVIzazOlZqbUplpKLZFenaR3zQbbv5Q_MSXAmxPAkrN9F21wnh5wSkCp7j1eHnGYvnfvMRpyKQiHrY_oRtMO_t8-Pjyiuz5Fl168wwPSQ7-GpAHzfZqvabxEEqnqNFy_AQcwy30
CODEN JACIBY
CitedBy_id crossref_primary_10_1002_ppul_26569
crossref_primary_10_1002_alr_23090
crossref_primary_10_1016_j_intimp_2023_110623
crossref_primary_10_1016_j_aller_2019_06_007
crossref_primary_10_1016_j_bjorl_2017_10_006
crossref_primary_10_1371_journal_pone_0279748
crossref_primary_10_3389_fphar_2022_869162
crossref_primary_10_1002_iid3_418
crossref_primary_10_2500_ajra_2013_27_3928
crossref_primary_10_3389_falgy_2022_980515
crossref_primary_10_3389_fped_2021_709139
crossref_primary_10_1007_s40521_013_0007_4
crossref_primary_10_1016_j_reval_2014_10_005
crossref_primary_10_1002_alr_21992
crossref_primary_10_1002_lio2_208
crossref_primary_10_1016_j_sapharm_2020_05_012
crossref_primary_10_1002_clt2_12077
crossref_primary_10_1016_j_bjorl_2015_12_011
crossref_primary_10_1159_000524498
crossref_primary_10_1177_1721727X1301100203
crossref_primary_10_1016_j_waojou_2019_100027
crossref_primary_10_1002_lary_31347
crossref_primary_10_1002_clt2_12191
crossref_primary_10_1038_s41533_022_00315_6
crossref_primary_10_1097_ACI_0000000000000020
crossref_primary_10_1111_jvim_14629
crossref_primary_10_4168_aard_2017_5_4_175
crossref_primary_10_1002_lary_28879
crossref_primary_10_1007_s12070_020_01907_9
crossref_primary_10_1111_jdv_19862
crossref_primary_10_1111_all_13362
crossref_primary_10_1111_pai_13454
crossref_primary_10_1002_alr_22073
crossref_primary_10_1016_j_jaip_2020_02_023
crossref_primary_10_3389_fphar_2021_798263
crossref_primary_10_1002_alr_22390
crossref_primary_10_1016_j_anai_2017_08_006
crossref_primary_10_3390_jcm9072226
crossref_primary_10_1002_clt2_12062
crossref_primary_10_1016_j_sapharm_2022_03_017
crossref_primary_10_4168_aard_2017_5_4_205
crossref_primary_10_1111_all_12518
crossref_primary_10_1016_j_jaci_2020_07_007
crossref_primary_10_1155_2022_4666332
crossref_primary_10_1080_02770903_2018_1534969
crossref_primary_10_1155_2016_9471215
crossref_primary_10_1016_j_japh_2022_02_009
crossref_primary_10_1186_s13063_020_04614_6
crossref_primary_10_1111_all_15199
crossref_primary_10_2500_ajra_2016_30_4260
crossref_primary_10_2500_ajra_2015_29_4215
crossref_primary_10_1177_1945892419884789
crossref_primary_10_3389_fnut_2023_1291100
crossref_primary_10_1016_j_joim_2022_08_004
crossref_primary_10_1016_j_anai_2019_03_017
crossref_primary_10_1016_j_rmed_2020_106066
crossref_primary_10_1016_j_anai_2022_08_014
crossref_primary_10_3390_jcm8112019
crossref_primary_10_58931_cpct_2023_1S0511
crossref_primary_10_1016_j_jaip_2014_01_005
crossref_primary_10_2174_1871530319666190306100611
crossref_primary_10_1186_s12948_018_0082_y
crossref_primary_10_2500_ajra_2016_30_4391
crossref_primary_10_1016_j_jaip_2014_01_001
crossref_primary_10_1016_j_anai_2017_02_007
crossref_primary_10_1111_coa_12841
crossref_primary_10_1111_all_15207
crossref_primary_10_1016_j_jaip_2024_04_030
crossref_primary_10_1016_j_jaip_2024_04_031
crossref_primary_10_3389_fped_2023_1244146
crossref_primary_10_1016_j_jaip_2021_09_035
crossref_primary_10_4193_Rhin21_282
crossref_primary_10_1007_s11655_020_3099_2
crossref_primary_10_2500_aap_2021_42_210052
crossref_primary_10_1016_j_iac_2015_12_006
crossref_primary_10_1016_j_iac_2015_12_002
crossref_primary_10_1016_j_jaip_2019_01_015
crossref_primary_10_1097_MPG_0000000000002583
crossref_primary_10_1002_alr_22659
crossref_primary_10_1177_0009922814533590
crossref_primary_10_2217_imt_2021_0353
Cites_doi 10.1034/j.1399-3003.1999.14d29.x
10.1016/j.jaci.2003.09.008
10.1016/S0091-6749(97)80040-1
10.1067/mai.2001.115566
10.1016/j.jaci.2006.01.011
10.1023/A:1014485627744
10.1016/j.anai.2009.11.063
10.2500/aap.2009.30.3230
10.1016/S1081-1206(10)60488-7
10.1016/S0895-4356(99)00071-2
10.1185/03007990802711602
10.2500/aap.2007.28.2934
10.1097/01.MLR.0000062554.74615.4C
10.1016/S0091-6749(97)80041-3
10.2165/11318410-000000000-00000
10.4065/77.4.371
ContentType Journal Article
Copyright American Academy of Allergy, Asthma & Immunology
2012 American Academy of Allergy, Asthma & Immunology
2014 INIST-CNRS
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Copyright Elsevier Limited Feb 2013
Copyright_xml – notice: American Academy of Allergy, Asthma & Immunology
– notice: 2012 American Academy of Allergy, Asthma & Immunology
– notice: 2014 INIST-CNRS
– notice: Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
– notice: Copyright Elsevier Limited Feb 2013
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7SS
7T5
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.jaci.2012.10.022
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts

MEDLINE - Academic

MEDLINE
Entomology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 386
ExternalDocumentID 3555923221
10_1016_j_jaci_2012_10_022
23219170
27105701
S0091674912016909
1_s2_0_S0091674912016909
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: GlaxoSmithKline
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
3V.
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
7RV
7X7
8C1
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFO
ACGFS
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
ADVLN
AEBSH
AEKER
AENEX
AFFNX
AFJKZ
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BBNVY
BENPR
BHPHI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HCIFZ
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M2O
M41
M7P
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
08R
AALMO
ABFLS
ABPIF
ADALY
ADGIM
BBAFP
BKEYQ
IPNFZ
IQODW
PQEST
PQUKI
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7SS
7T5
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c502t-cc8190435845164b891f082c8fe46d7077f88d5fc5cdb284b0a4d2730aefbfc23
IEDL.DBID AIKHN
ISSN 0091-6749
IngestDate Sat Aug 17 01:19:54 EDT 2024
Thu Jul 25 11:15:39 EDT 2024
Thu Oct 10 18:10:19 EDT 2024
Thu Sep 26 15:36:17 EDT 2024
Sat Sep 28 07:51:12 EDT 2024
Thu Nov 24 18:30:57 EST 2022
Fri Feb 23 02:26:43 EST 2024
Tue Oct 15 22:55:42 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords PAR
Rhinitis Control Assessment Test
RCAT
Seasonal allergic rhinitis
Perennial allergic rhinitis
SAR
ROC
MID
PRO
nonallergic rhinitis
Receiver operating characteristic
Allergic rhinitis
patient-reported outcome
rhinitis control
Minimal important difference
TNSS
Total Nasal Symptom Score
NAR
Human
Allergy
Immunopathology
Nose disease
Prognosis
Rhinitis
Validity
Immunology
ENT disease
Evolution
Reliability
Language English
License CC BY 4.0
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c502t-cc8190435845164b891f082c8fe46d7077f88d5fc5cdb284b0a4d2730aefbfc23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 23219170
PQID 1644750604
PQPubID 105664
PageCount 8
ParticipantIDs proquest_miscellaneous_1323813088
proquest_miscellaneous_1284286401
proquest_journals_1644750604
crossref_primary_10_1016_j_jaci_2012_10_022
pubmed_primary_23219170
pascalfrancis_primary_27105701
elsevier_sciencedirect_doi_10_1016_j_jaci_2012_10_022
elsevier_clinicalkeyesjournals_1_s2_0_S0091674912016909
PublicationCentury 2000
PublicationDate 2013-02-01
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-02-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2013
Publisher Mosby, Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Mosby, Inc
– name: Elsevier
– name: Elsevier Limited
References Nathan, Sorkness, Kosinski, Schatz, Li, Marcus (bib7) 2004; 113
Nunnally, Bernstein (bib13) 1994
Nathan, Meltzer, Selner, Storms (bib1) 1997; 99
Nathan (bib2) 2007; 28
Wyrwich, Tierney, Wolinsky (bib17) 1999; 52
Juniper, O'Byrne, Guyatt (bib9) 1999; 14
Nathan, Dalal, Stanford, Meltzer, Schatz, Derebery (bib11) 2010; 3
Kerlinger (bib15) 1973
(bib21) 2008
Schatz, Zeiger, Chen, Yang, Corrao, Quinn (bib6) 2008; 101
Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda: US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute, National Asthma Education and Prevention Program; 2007. NIH publication no. 07-40511-440. Available at
Cohen (bib14) 1988
Wyrwich, Tierney, Wolinsky (bib18) 2002; 11
Meltzer, Nathan, Derebery, Stang, Campbell, Yeh (bib3) 2009; 30
Accessed October 1, 2012.
Schatz, Meltzer, Nathan, Derebery, Mintz, Stanford (bib12) 2010; 104
Kosinski, Kite, Yang, Carranza-Rozenzwieg, Williams (bib20) 2009; 25
Norman, Sloan, Wyrwich (bib16) 2003; 41
Guyatt, Osborn, Wu, Wywrich, George (bib19) 2002; 77
Meltzer, Nathan, Selner, Storms (bib5) 1997; 99
Schatz, Sorkness, Li, Marcus, Murray, Nathan (bib8) 2006; 117
Meltzer (bib4) 2001; 108
Guyatt (10.1016/j.jaci.2012.10.022_bib19) 2002; 77
Nathan (10.1016/j.jaci.2012.10.022_bib2) 2007; 28
Wyrwich (10.1016/j.jaci.2012.10.022_bib18) 2002; 11
Schatz (10.1016/j.jaci.2012.10.022_bib12) 2010; 104
Nathan (10.1016/j.jaci.2012.10.022_bib7) 2004; 113
Wyrwich (10.1016/j.jaci.2012.10.022_bib17) 1999; 52
Nathan (10.1016/j.jaci.2012.10.022_bib1) 1997; 99
Kosinski (10.1016/j.jaci.2012.10.022_bib20) 2009; 25
Nathan (10.1016/j.jaci.2012.10.022_bib11) 2010; 3
Meltzer (10.1016/j.jaci.2012.10.022_bib3) 2009; 30
Cohen (10.1016/j.jaci.2012.10.022_bib14) 1988
Meltzer (10.1016/j.jaci.2012.10.022_bib4) 2001; 108
Juniper (10.1016/j.jaci.2012.10.022_bib9) 1999; 14
Kerlinger (10.1016/j.jaci.2012.10.022_bib15) 1973
Meltzer (10.1016/j.jaci.2012.10.022_bib5) 1997; 99
Schatz (10.1016/j.jaci.2012.10.022_bib6) 2008; 101
Nunnally (10.1016/j.jaci.2012.10.022_bib13) 1994
(10.1016/j.jaci.2012.10.022_bib21) 2008
10.1016/j.jaci.2012.10.022_bib10
Schatz (10.1016/j.jaci.2012.10.022_bib8) 2006; 117
Norman (10.1016/j.jaci.2012.10.022_bib16) 2003; 41
References_xml – volume: 104
  start-page: 118
  year: 2010
  end-page: 124
  ident: bib12
  article-title: Psychometric validation of the Rhinitis Control Assessment Test (RCAT): a brief, self administered instrument for evaluating rhinitis symptom control
  publication-title: Ann Allergy Asthma Immunol
  contributor:
    fullname: Stanford
– volume: 101
  start-page: 240
  year: 2008
  end-page: 247
  ident: bib6
  article-title: The burden of rhinitis in a managed care organization
  publication-title: Ann Allergy Asthma Immunol
  contributor:
    fullname: Quinn
– year: 1994
  ident: bib13
  article-title: Psychometric theory
  contributor:
    fullname: Bernstein
– volume: 99
  start-page: S808
  year: 1997
  end-page: S814
  ident: bib1
  article-title: Prevalence of allergic rhinitis in the United States
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Storms
– volume: 99
  start-page: S815
  year: 1997
  end-page: S819
  ident: bib5
  article-title: Quality of life and rhinitis symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Storms
– volume: 117
  start-page: 549
  year: 2006
  end-page: 556
  ident: bib8
  article-title: The Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Nathan
– volume: 25
  start-page: 717
  year: 2009
  end-page: 727
  ident: bib20
  article-title: Comparability of Asthma Control Test telephone interview administration format with self-administered mail-out mail-back format
  publication-title: Curr Med Res Opin
  contributor:
    fullname: Williams
– volume: 52
  start-page: 861
  year: 1999
  end-page: 873
  ident: bib17
  article-title: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life
  publication-title: J Clin Epidemiol
  contributor:
    fullname: Wolinsky
– volume: 11
  start-page: 1
  year: 2002
  end-page: 7
  ident: bib18
  article-title: Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire
  publication-title: Qual Life Res
  contributor:
    fullname: Wolinsky
– year: 1973
  ident: bib15
  article-title: Foundations of behavioral research
  contributor:
    fullname: Kerlinger
– volume: 3
  start-page: 91
  year: 2010
  end-page: 99
  ident: bib11
  article-title: Qualitative development of the Rhinitis Control Assessment Test (RCAT), an instrument for evaluating rhinitis symptom control
  publication-title: The Patient: Patient Centered Outcomes Research
  contributor:
    fullname: Derebery
– volume: 108
  start-page: S45
  year: 2001
  end-page: S53
  ident: bib4
  article-title: Quality of life in adults and children with allergic rhinitis
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Meltzer
– volume: 77
  start-page: 317
  year: 2002
  end-page: 383
  ident: bib19
  article-title: Methods to explain the clinical significance of health status measures
  publication-title: Mayo Clin Proc
  contributor:
    fullname: George
– volume: 28
  start-page: 3
  year: 2007
  end-page: 9
  ident: bib2
  article-title: The burden of allergic rhinitis
  publication-title: Allergy Asthma Proc
  contributor:
    fullname: Nathan
– volume: 14
  start-page: 902
  year: 1999
  end-page: 907
  ident: bib9
  article-title: Development and validation of a questionnaire to measure asthma control
  publication-title: Eur Respir J
  contributor:
    fullname: Guyatt
– volume: 30
  start-page: 244
  year: 2009
  end-page: 254
  ident: bib3
  article-title: Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey
  publication-title: Allergy Asthma Proc
  contributor:
    fullname: Yeh
– year: 1988
  ident: bib14
  article-title: Statistical power analysis for the Behavioral Sciences
  contributor:
    fullname: Cohen
– volume: 41
  start-page: 582
  year: 2003
  end-page: 592
  ident: bib16
  article-title: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation
  publication-title: Med Care
  contributor:
    fullname: Wyrwich
– volume: 113
  start-page: 59
  year: 2004
  end-page: 65
  ident: bib7
  article-title: Development of the Asthma Control Test (ACT): a survey for assessing asthma control
  publication-title: J Allergy Clin Immunol
  contributor:
    fullname: Marcus
– year: 2008
  ident: bib21
  article-title: FDA guidance for industry, patient reported outcome measures: use in medical product development to support labeling claims
– volume: 14
  start-page: 902
  year: 1999
  ident: 10.1016/j.jaci.2012.10.022_bib9
  article-title: Development and validation of a questionnaire to measure asthma control
  publication-title: Eur Respir J
  doi: 10.1034/j.1399-3003.1999.14d29.x
  contributor:
    fullname: Juniper
– volume: 113
  start-page: 59
  year: 2004
  ident: 10.1016/j.jaci.2012.10.022_bib7
  article-title: Development of the Asthma Control Test (ACT): a survey for assessing asthma control
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2003.09.008
  contributor:
    fullname: Nathan
– ident: 10.1016/j.jaci.2012.10.022_bib10
– volume: 99
  start-page: S808
  issue: suppl
  year: 1997
  ident: 10.1016/j.jaci.2012.10.022_bib1
  article-title: Prevalence of allergic rhinitis in the United States
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(97)80040-1
  contributor:
    fullname: Nathan
– volume: 108
  start-page: S45
  issue: suppl
  year: 2001
  ident: 10.1016/j.jaci.2012.10.022_bib4
  article-title: Quality of life in adults and children with allergic rhinitis
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2001.115566
  contributor:
    fullname: Meltzer
– volume: 117
  start-page: 549
  year: 2006
  ident: 10.1016/j.jaci.2012.10.022_bib8
  article-title: The Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2006.01.011
  contributor:
    fullname: Schatz
– volume: 11
  start-page: 1
  year: 2002
  ident: 10.1016/j.jaci.2012.10.022_bib18
  article-title: Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire
  publication-title: Qual Life Res
  doi: 10.1023/A:1014485627744
  contributor:
    fullname: Wyrwich
– volume: 104
  start-page: 118
  year: 2010
  ident: 10.1016/j.jaci.2012.10.022_bib12
  article-title: Psychometric validation of the Rhinitis Control Assessment Test (RCAT): a brief, self administered instrument for evaluating rhinitis symptom control
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2009.11.063
  contributor:
    fullname: Schatz
– volume: 30
  start-page: 244
  year: 2009
  ident: 10.1016/j.jaci.2012.10.022_bib3
  article-title: Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey
  publication-title: Allergy Asthma Proc
  doi: 10.2500/aap.2009.30.3230
  contributor:
    fullname: Meltzer
– volume: 101
  start-page: 240
  year: 2008
  ident: 10.1016/j.jaci.2012.10.022_bib6
  article-title: The burden of rhinitis in a managed care organization
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/S1081-1206(10)60488-7
  contributor:
    fullname: Schatz
– volume: 52
  start-page: 861
  year: 1999
  ident: 10.1016/j.jaci.2012.10.022_bib17
  article-title: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(99)00071-2
  contributor:
    fullname: Wyrwich
– volume: 25
  start-page: 717
  year: 2009
  ident: 10.1016/j.jaci.2012.10.022_bib20
  article-title: Comparability of Asthma Control Test telephone interview administration format with self-administered mail-out mail-back format
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007990802711602
  contributor:
    fullname: Kosinski
– volume: 28
  start-page: 3
  year: 2007
  ident: 10.1016/j.jaci.2012.10.022_bib2
  article-title: The burden of allergic rhinitis
  publication-title: Allergy Asthma Proc
  doi: 10.2500/aap.2007.28.2934
  contributor:
    fullname: Nathan
– year: 1994
  ident: 10.1016/j.jaci.2012.10.022_bib13
  contributor:
    fullname: Nunnally
– year: 1988
  ident: 10.1016/j.jaci.2012.10.022_bib14
  contributor:
    fullname: Cohen
– volume: 41
  start-page: 582
  year: 2003
  ident: 10.1016/j.jaci.2012.10.022_bib16
  article-title: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation
  publication-title: Med Care
  doi: 10.1097/01.MLR.0000062554.74615.4C
  contributor:
    fullname: Norman
– year: 2008
  ident: 10.1016/j.jaci.2012.10.022_bib21
– volume: 99
  start-page: S815
  issue: suppl
  year: 1997
  ident: 10.1016/j.jaci.2012.10.022_bib5
  article-title: Quality of life and rhinitis symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(97)80041-3
  contributor:
    fullname: Meltzer
– volume: 3
  start-page: 91
  year: 2010
  ident: 10.1016/j.jaci.2012.10.022_bib11
  article-title: Qualitative development of the Rhinitis Control Assessment Test (RCAT), an instrument for evaluating rhinitis symptom control
  publication-title: The Patient: Patient Centered Outcomes Research
  doi: 10.2165/11318410-000000000-00000
  contributor:
    fullname: Nathan
– year: 1973
  ident: 10.1016/j.jaci.2012.10.022_bib15
  contributor:
    fullname: Kerlinger
– volume: 77
  start-page: 317
  year: 2002
  ident: 10.1016/j.jaci.2012.10.022_bib19
  article-title: Methods to explain the clinical significance of health status measures
  publication-title: Mayo Clin Proc
  doi: 10.4065/77.4.371
  contributor:
    fullname: Guyatt
SSID ssj0009389
Score 2.4450727
Snippet Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the...
The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. We sought to test the reliability,...
BACKGROUNDThe Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control.OBJECTIVEWe sought to test the...
Background: The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective: We sought to test...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 379
SubjectTerms Adolescent
Adult
Aged
Allergic rhinitis
Allergies
Allergy and Immunology
Asthma
Biological and medical sciences
Diagnostic Self Evaluation
Disease control
Evaluation Studies as Topic
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Geriatrics
Humans
Immunopathology
Longitudinal Studies
Male
Medical sciences
Middle Aged
Non tumoral diseases
nonallergic rhinitis
Nose
Otorhinolaryngology. Stomatology
patient-reported outcome
Patients
Ratings & rankings
Reproducibility of Results
Review boards
Rhinitis
Rhinitis - diagnosis
Rhinitis - physiopathology
rhinitis control
Rhinitis Control Assessment Test
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Severity of Illness Index
Surveys and Questionnaires
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Validity
Young Adult
Title Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0091674912016909
https://dx.doi.org/10.1016/j.jaci.2012.10.022
https://www.ncbi.nlm.nih.gov/pubmed/23219170
https://www.proquest.com/docview/1644750604
https://search.proquest.com/docview/1284286401
https://search.proquest.com/docview/1323813088
Volume 131
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OHogg4rfRs6zgm-Yu2WySzWMpHlXxHuQO7m3JfmFOSEvTe_DFv92Z7qblkPrgW0mzyXRmdubX5DczAO9dYaVHR0htW9PTqtylmIQr3O61FlzYtrVblu9FtbgSX67L6yOYj7UwRKuMsT_E9G20jkfOojbPVl1HNb4NUeibnFNHESriO8Z0JMQEjmefvy4u9r13CxlQcJOntCDWzgSa101rOmJ48VMieXF-KD89XLUDas2HcReH8eg2L50_hkcRULJZkPkJHLn-Kdz_Fl-ZP4OfRDoOzbh_fWToV53dfmp7y9aRIBsCHlt6hnCQff_REaNoYPNAY2ezXfdOdomisK5nsR3rwOg5LlvHFc_h6vzT5XyRxgkLqSkzvkmNIUCAiEnSvF6hZZN7xARGeicqW2d17aW0pTelsRoTmc5aYRHwZK3z2htevIBJv-zdK2BNpjPPi1KXshGVKxurHdrG1Do3srAugQ-jXtUqNNJQI8PsRpEVFFmBjqEVEqhH1auxRBSDmhviDhtUrgauMvWXFyRQ7lbecSSFOeKfd5zesfBOSF7TKOQsT-BkNLnaS1FRw0RqQJTAu93XuEPptUvbu-UtnoOK47ISdImD5xQEnQoM-Qm8DO60F6Dg9Kc6e_2fv-wNPODbGR7EwTmByWZ9694iktroKdw7_Z1P4375A0vsHBg
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB5CAm2hhL6rNkm30FurRFq9VsdgEtw2yaE4kNuifRGlIBvLOfTS394Z7comFPfQm5FX0nhmduaz9M0MwCebGeHQEWLTVPS0KrUxJuESt3ulcp6bpjEDy_eqnF7n326Kmx2YjLUwRKsMsd_H9CFahyMnQZsni7alGt-aKPR1yqmjCBXx7REaIF7X8e8Nz6POhMfAdRrT8lA540led41uid_Fj4nixfm27PR00fSoM-eHXWxHo0NWOn8G-wFOslMv8XPYsd0LeHQZXpi_hJ9EOfatuH99YehVrRk-NZ1hy0CP9eGOzR1DMMh-3LbEJ-rZxJPY2em6dyeboSis7VhoxtozeorLluGMV3B9fjabTOMwXyHWRcJXsdYEBxAvCZrWmytRpw4RgRbO5qWpkqpyQpjC6UIbhWlMJU1uEO4kjXXKaZ69ht1u3tm3wOpEJY5nhSpEnZe2qI2yaBldqVSLzNgIPo96lQvfRkOO_LI7SVaQZAU6hlaIoBpVL8cCUQxptg_7q5ep7LlM5F8-EEGxPvOBG0nMEP-849EDC6-F5BUNQk7SCA5Gk8uNFCW1S6T2QxF8XH-N-5NeujSdnd_jGlQcF2VOl9i6JiPglGHAj-CNd6eNABmnv9TJu__8ZR_g8XR2eSEvvl59fw9P-DDNg9g4B7C7Wt7bQ8RUK3U07Jk_1wgc7Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reliability%2C+validity%2C+and+responsiveness+of+the+Rhinitis+Control+Assessment+Test+in+patients+with+rhinitis&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Meltzer%2C+Eli+O.&rft.au=Schatz%2C+Michael&rft.au=Nathan%2C+Robert&rft.au=Garris%2C+Cindy&rft.date=2013-02-01&rft.issn=0091-6749&rft.volume=131&rft.issue=2&rft.spage=379&rft.epage=386&rft_id=info:doi/10.1016%2Fj.jaci.2012.10.022&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jaci_2012_10_022
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674913X00028%2Fcov150h.gif